Staar Surgical Co Quick Ratio (STAA) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Staar Surgical Co  (NASDAQ: STAA)

Staar Surgical Co's Quick Ratio

STAA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Staar Surgical Co's Cash & cash equivalent grew by 13.73 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Staar Surgical Co's Quick Ratio to 2.73, above Staar Surgical Co average Quick Ratio.

Within Medical Equipment & Supplies industry 66 other companies have achieved higher Quick Ratio than Staar Surgical Co in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 1215, from total ranking in the second quarter 2026 at 1460.

Explain Quick Ratio?
How much Cash & cash equivalents STAA´s has?
What are STAA´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/STAA/financial-strength
https://api.csimarket.com/api/v1/companies/STAA/fundamentals
https://api.csimarket.com/api/v1/companies/STAA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
STAA Quick Ratio (Oct 02 2026)
Q3
(Jul 03 2026)
Q2
(Apr 03 2026)
Q1
(Jan 02 2026)
Q4
(Sep 26 2025)
Q3
Y / Y Current Liabilities Change 22.56 %
Y / Y Cash & cash equivalent Change 7.14 %
Quick Ratio MRQ 2.73
STAA's Total Ranking # 1215
Seq. Current Liabilities Change 2.93 %
Seq. Cash & cash equivalent Change 13.73 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 67
Healthcare Sector # 424
Overall Market # 1187


Quick Ratio Statistics
High Average Low
4.69 2.4 0.5
(Apr 01 2022)   (Apr 01 2016)




Financial Statements
Staar Surgical Co's Current Liabilities $ 76 Millions Visit STAA's Balance sheet
Staar Surgical Co's Cash & cash equivalent $ 206 Millions Visit STAA's Balance sheet
Source of STAA's Sales Visit STAA's Sales by Geography


Cumulative Staar Surgical Co's Quick Ratio

STAA's Quick Ratio for the trailling 12 Months

STAA Quick Ratio

(Oct 02 2026)
12 Months
(Jul 03 2026)
12 Months
(Apr 03 2026)
12 Months
(Jan 02 2026)
12 Months
(Sep 26 2025)
12 Months
Y / Y Current Liabilities TTM Growth -4.98 %
Y / Y Cash & cash equivalent TTM Growth -11.54 %
Quick Ratio TTM 2.66
Total Ranking TTM # 3790
Seq. Current Liabilities TTM Growth 5.26 %
Seq. Cash & cash equivalent TTM Growth 1.9 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $75.54 millions, cumulative Quick Ratio decreased to 2.66 above the STAA average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 197 other companies have achieved higher Quick Ratio than Staar Surgical Co. While Quick Ratio overall ranking has improved so far to 3790, from total ranking during the twelve months ending second quarter 2026 at 3804.

Explain Quick Ratio?
How much Cash & cash equivalents STAA´s has?
What are STAA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 198
Healthcare Sector # 878
Within the Market # 3790


trailing twelve months Quick Ratio Statistics
High Average Low
4.32 2.23 0.62
(Jul 01 2022)   (Dec 30 2016)




Companies with similar Quick Ratio in the quarter ending Oct 02 2026, within Medical Equipment & Supplies Industry Quick RatioOct 02 2026 MRQ Cash & cash equivalentOct 02 2026 MRQ Current Liabilities
Orchestra Biomed Holdings Inc   7.16 $ 101.907  Millions$ 14.228  Millions
Envveno Medical Corporation  7.13 $ 18.472  Millions$ 2.589  Millions
Ceribell Inc   6.51 $ 117.467  Millions$ 18.034  Millions
Autonomix Medical Inc   6.13 $ 7.692  Millions$ 1.254  Millions
Iradimed Corporation  6.13 $ 63.288  Millions$ 10.323  Millions
Orasure Technologies Inc  5.90 $ 148.238  Millions$ 25.104  Millions
Perspective Therapeutics Inc   5.09 $ 201.695  Millions$ 39.602  Millions
Clearpoint Neuro Inc   4.68 $ 46.184  Millions$ 9.869  Millions
Cvrx inc   4.67 $ 58.746  Millions$ 12.583  Millions
Dexcom Inc   4.25 $ 964.800  Millions$ 227.000  Millions
Innovative Eyewear Inc   3.86 $ 3.197  Millions$ 0.829  Millions
Sight Sciences Inc   3.84 $ 77.402  Millions$ 20.137  Millions
Alpha Pro Tech Ltd   3.78 $ 25.546  Millions$ 6.750  Millions
Hyperfine Inc   3.60 $ 37.872  Millions$ 10.532  Millions
Profound Medical Corp   3.41 $ 33.343  Millions$ 9.771  Millions
Rxsight Inc   3.40 $ 254.683  Millions$ 74.952  Millions
Omada Health Inc   3.23 $ 243.151  Millions$ 75.379  Millions
Transmedics Group Inc   3.22 $ 492.962  Millions$ 152.857  Millions
Trisalus Life Sciences Inc   3.15 $ 41.057  Millions$ 13.014  Millions
Procept Biorobotics Corporation  3.10 $ 218.369  Millions$ 70.353  Millions
Carlsmed Inc   3.08 $ 56.207  Millions$ 18.237  Millions
Outset Medical Inc   3.07 $ 136.627  Millions$ 44.453  Millions
Sharps Technology Inc   2.82 $ 7.478  Millions$ 2.650  Millions
Edwards Lifesciences Corporation  2.81 $ 4,683.700  Millions$ 1,664.300  Millions
Mimedx Group Inc   2.81 $ 120.791  Millions$ 43.031  Millions
Pulse Biosciences Inc   2.74 $ 36.725  Millions$ 13.395  Millions
Staar Surgical Co  2.73 $ 206.414  Millions$ 75.541  Millions
Medinotec Inc   2.68 $ 2.584  Millions$ 0.963  Millions
Glaukos Corp  2.66 $ 337.478  Millions$ 126.726  Millions
Pulmonx Corporation  2.57 $ 53.245  Millions$ 20.739  Millions

Date modified: 2026-11-05T14:29:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.